TWiV 610: Coronavirus FAQ
The TWiV team summarizes serology-based tests for SARS-CoV-2, lack of effect of ACE inhibitors or ARBs on COVID-19 severity, and answers listener questions. Hosts: Vincent Racaniello, Rich Condit, Ka...
7 Touko 20201h 38min
TWiV 609: A coronavirus chronology with Susan Weiss
Susan Weiss recalls some of her 40 years of research on coronaviruses, including mouse hepatitis virus, MERS-CoV, and now SARS-CoV-2. Hosts: Vincent Racaniello, Dickson Despommier, Alan Dove, Rich Co...
3 Touko 20201h 14min
TWiV 608: Daniel Griffin's COVID-19 clinical report
Daniel Griffin updates the clinical situation with COVID-19 patients, followed by analysis of the remedesivir clinical trial results, and answers listener questions. Hosts: Vincent Racaniello and Ric...
1 Touko 202057min
TWiV 607: Coronavirus epidemiology with Jeff Shaman
Jeff Shaman returns to TWiV to explain why more SARS-CoV-2 testing and contact tracing is needed to stop the pandemic, and provide insights on immunity and reinfection from seasonal CoVs, the problems...
29 Huhti 20201h 7min
TWiV 606: Evidence-based science and medicine for COVID-19
Daniel Griffin provides his weekly update on the COVID-19 clinical situation, followed by our discussion of tests of an inactivated vaccine, results of serological surveys, an inhibitor of the cell pr...
26 Huhti 20201h 54min
TWiV 605: READDI for the next pandemic
Ralph Baric, Mark Heise and Nat Moorman discuss their non-profit initiative READDI, Rapidly Emerging Antiviral Drug Discovery Initiative, to start making drugs now for the next pandemic virus. Hosts: ...
23 Huhti 202052min
TWiV 604: Oral poliovaccine to prevent SARS-CoV-2 infection
Kostya Chumakov discusses the hypothesis that oral poliovirus vaccine can provide non-specific protection against many other viruses, and might prevent infection with SARS-CoV-2. Host: Vincent Racanie...
21 Huhti 20201h 4min
TWiV 603: Cloudy with a chance of coronavirus
Daniel Griffin provides his weekly update on the COVID-19 clinical situation, followed by results of seroprevalence studies, analysis of CpG dinucleotide frequencies in the SARS-CoV-2 genome, and answ...
19 Huhti 20201h 56min
